Preliminary
Clinical Translation — Clinical trials, drug repurposing, regulatory pathways, and geroprotectors in humans
Review / Commentary
PubMed
If your immune system ages slower, your lungs might stay healthier longer—but we need better treatments to prove it works.
Immunosenescence drives multiple age-related lung pathologies; review of senolytics, immunotherapy, and stem cell interventions reveals promising mechanisms but limited Phase 3 evidence and heterogeneous patient responses.
This review examines how immunosenescence (age-related immune decline) drives lung diseases like COPD, fibrosis, and cancer, and surveys emerging treatments including senolytics, stem cell therapy, and lifestyle interventions. While it synthesizes current knowledge well, it's …
BMC medicine